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Atomic force microscopic imaging of seeded fibril formation and 
fibril branching by the Alzheimer’s disease amyloid-p protein 
James D Harper ly2, Charles M Lieber3 and Peter T Lansbury, Jr2 
Background: Amyloid plaques composed of the fibrillar form of the amyloid-P 
protein (AP) are the defining neuropathological feature of Alzheimer’s disease 
(AD). A detailed understanding of the time course of amyloid formation could 
define steps in disease progression and provide targets for therapeutic 
intervention. Amyloid fibrils, indistinguishable from those derived from an AD 
brain, can be produced in vitro using a seeded polymerization mechanism. In its 
simplest form, this mechanism involves a cooperative transition from monomeric 
A@ to the amyloid fibril without the buildup of intermediates. Recently, however, 
a transient species, the Aj3 amyloid protofibril, has been identified. Here, we 
report studies of AP amyloid protofibril and its seeded transition into amyloid 
fibrils using atomic force microscopy. 
Results: Seeding of the protofibril-to-fibril transition was observed. Preformed 
fibrils, but not protofibrils, effectively seeded this transition. The assembly state 
of AP influenced the rate of seeded growth, indicating that protofibrils are fibril 
assembly precursors. The handedness of the helical surface morphology of 
fibrils depended on the chirality of AP. Finally, branched and partially wound 
fibrils were observed. 
Conclusions: The temporal evolution of morphologies suggests that the 
protofibril-to-fibril transition is nucleation-dependent and that protofibril winding 
is involved in that transition. Fibril unwinding and branching may be essential for 
the post-nucleation growth process. The protofibrillar assembly intermediate is 
a potential target for AD therapeutics aimed at inhibiting amyloid formation and 
AD diagnostics aimed at detecting presymptomatic disease. 
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Introduction 
Amyloid plaque in the brain is the unique and defining 
feature of Alzheimer’s disease (AD) and convergent evi- 
dence strongly suggests that it plays a central role in the 
pathogenesis of AD [l-3]. Thus, endogenous factors that 
increase the rate of amyloid formation could accelerate 
the onset of AD, whereas those that inhibit amyloid for- 
mation may delay its onset and slow its progression. Elu- 
cidation of the mechanism of amyloid fibril formation 
would facilitate the design of compounds that inhibit 
amyloid formation (potential therapeutic agents) [4] or 
detect and report its early stages (potential diagnostic 
agents) [Z]. 
The insoluble fibrillar core of the AD amyloid plaque com- 
prises variants of a normal protein known as amyloid-B 
protein (AB); ABl-40 and ABl-42 are the predominant 
forms [l-3], and both form fibrils in vitro by a seeded poly- 
merization mechanism [S]. The observation that nucleation 
of the ABl-42 libril is significantly faster than that of the 
ABl-40 fibril led to the proposal that ABl-42 could be the 
pathogenic variant [5,6]. Consistent with this, it has since 
been demonstrated that all forms of rare, early-onset AD 
involve increased expression of ABl-42 [3]. Overproduction 
of ABl-42, however, does not appear to be a feature of most 
late-onset AD cases; in fact, the increased amyloid load in 
these patients is comprised primarily of ABl-40 [7]. 
In vitro studies have led to a simple cooperative two-state 
model of libril formation in which only monomeric AB and 
fibrillar AB are significantly populated at any time during 
libril formation [S]. In order to test this hypothesis, we uti- 
lized atomic force microscopy (AFM) to observe the early 
stages of amyloid libril formation [9]. Because AFM pro- 
vides a three-dimensional characterization of the fibril, it 
offers a distinct advantage over traditional electron 
microscopy [lo]. For AFM analysis, the sample is adsorbed 
onto an atomically smooth surface (e.g., mica) and ana- 
lyzed directly by sensing the adsorbed material with a 
microfabricated silicon tip attached to a sensitive can- 
tilever [lo]. The resulting relief map is subsequently con- 
verted into a visual image. The resolution of this method is 
limited by the size and shape of the tip; current microfabri- 
cated silicon tips (the tips used in this study) have an 
average radius of around 10-15 nm, although carbon nano- 
tube tips that have smaller radii should enable significantly 
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higher resolution images to be obtained (S. Wong, J.D.H., 
P.T.L., and C.M.L., unpublished observations; [ll]). 
Although AFIL/I has many advantages for studying libril 
morphology, certain limitations must be taken into consid- 
eration when using AFM to study the pathway of fibril for- 
mation. First, as only adsorbed species are observed, one 
could fail to observe species that are prominent in solu- 
tion. Because the relative population of adsorbed species 
may not reflect their relative abundance in solution, con- 
clusions regarding the thermodynamics of the process 
cannot be drawn. The selective adsorption effect can be 
useful, however; for example, to trap a kinetically impor- 
tant species that is not abundant in solution and would be 
difficult to characterize using other methods. By observing 
the temporal evolution of selected A/3-derived species, 
one can construct a testable mechanistic model of fibril 
formation. The potential exists, provided that several 
technical obstacles can be overcome, to utilize AFM to 
study the kinetics of assembly of a single, surface-attached 
species in aqueous buffer. 
AFM images of early in vitro AB amyloid fibril formation 
have revealed the existence of a family of AB oligomers, of 
heterogeneous length, which differ from the much longer 
product fibrils with respect to their height and morphology 
[9,12]. These oligomers, collectively termed protofibrils, 
appear well before librils are observed, grow over a period 
of weeks in the absence of agitation (stirring significantly 
increases the rate of libril formation [5,8,9,13]), and then 
disappear rapidly as fibrils grow [9,12]. The protofibril is 
approximately 34 nm in height and has a periodicity of 
-20 nm, compared to the type 1 fibril (the first type of Iibril 
to be observed) which has a height of 7-8 nm and a period- 
icity of -40 nm. Two explanations for the transient appear- 
ance of the protofibril were put forward; the protofibril 
could be an off-pathway ‘reservoir phase’, in rapid equilib- 
rium with monomeric AB, or an on-pathway assembly inter- 
mediate, from which fibrils are constructed [9,12]. In the 
latter case, the protofibril would also be expected to be the 
preferred substrate for fibril growth. The rapid transition 
from 100-200 nm protofibrils to fibrils of greater than 1 ym 
in length, which occurs after a relatively long period in 
which the protofibrils grow from 30-50 nm to 100-200 nm, 
suggests that the transition is cooperative and could be 
seeded by preformed fibrils [9]. Clarification of these issues 
could have important implications for the development of 
AD therapeutics and diagnostics. 
Here we report the direct observation of the seeded poly- 
merization of API-40 using AFM. These studies demon- 
strate that protofibrils do not seed fibril formation but are 
the preferred substrates for addition to pre-existing fibril 
seeds. In addition, the observation of branched fibril mor- 
phologies is reported, which suggests a mechanistic model 
for seeded fibril growth. 
Results 
Both ABl-40 and ABl-42 follow an analogous pathway to 
form the fibril, including the early appearance of protofib- 
rils, followed by their elongation and eventual disappear- 
ance [9,12]. As fibrils form much faster in stirred 
incubations [5,9,13], the studies reported here were per- 
formed in the absence of agitation, to maximize our 
chances of observing early intermediates. In addition, the 
AB variant A/31-40, rather than ABl-42, was used because 
it is intrinsically less prone to form fibrils [5,9,12], making 
it easier to observe transient protofibrils. Although ABl-42 
seems to be the pathogenic species in early-onset familial 
AD [3], increased deposition of ABl-40 is characteristic of 
late-onset AD patients bearing the apoE allele (apoE is 
a susceptibility factor for late-onset AD) [7]. 
Protofibril growth is dependent on time and concentration 
Measurements of average protofibril length were made on 
aliquots removed from three ABl-40 samples (50, 100 and 
200 /.tM). After 14 h, the average protofibril length at 50 pM 
Apl-40 was 55 nm (range 27-128 nm, 6%> 100 nm), at 
100 PM, 69 nm (range 39-144 nm, 12%> 100 nm), and at 
200 pM, 79 nm (range 27-291 nm, 23%> 100 nm, many 
> 150 nm). The 100pM incubation was followed; after 
63 h, the average protofibril length was 83 nm (range 
30-242 nm, 30%> 100 nm), and after two weeks, the 
average length had reached 116 nm (range 20-595 nm, 
50% > 100 nm, 10% > 200 nm, some protofibrils >400nm). 
The observed length distribution was not dependent on 
the duration of the interaction with the mica surface (data 
not shown). It has also been demonstrated that the amount 
of ABl-40 (and ABl-42) in protofibrillar form, like the 
average protofibril length, increases over time [12]. 
Fibril formation can be seeded by preformed fibrils but not 
by protofibrils 
Addition of ABl-40 amyloid fibrils to a supersaturated 
solution of ABl-40 induces immediate polymerization, 
detected by a change in turbidity [5,13,14]. As observed by 
AFM, the conversion of protofibrils to amyloid fibrils was 
similarly accelerated by the addition of an aliquot from an 
ABl-40 incubation containing fibrils but no protofibrils. 
The total amount of A/31-40 in the seed aliquot was -1% of 
the amount present in the supersaturated solution, 
Figure 1. Addition of an aliquot (containing the same 
amount of total Apl-40) from an incubation containing 
protofibrils, but no fibrils, had no effect (data not shown). 
In the seeded conversion, fibrils were clearly visible after 3 
days; in the absence of seed, fibrils generally did not 
appear until at least 15 and usually >21 days had elapsed. 
Protofibrils were completely consumed in the seeded con- 
version by 14 days; in the absence of seed, protofibrils 
were visible after 30 days. Not all fibrillar preparations of 
ABl-40 were equally effective, suggesting that certain fib- 
rillar morphologies are more effective seeds. This may 
explain why the observation of heterogeneous seeding of 
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Figure 1 
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Fibrils seed the conversion of protofibrils to fibrils. (a) Three AFM images 
(2 urn square) taken at the indicated times following addition of - 1% 
preformed fibPil.seeds (based on initial A51 -40 concentration) to A51 -40 
at 100 PM. An unsegded AD1 -40 sample at the same concentration 
showed no evidence of of fibrils after 7 days (data not shown). (b) A 
mechanistic model, showing the key finding, that is preformed fibrils 
greatly accelerate the converison of protofibrils to fibrils. 
100 PM Afll-40 by Apl-42 fibrils was inconsistent and 
depended on the source of Apl-42 fibrils [8]. 
The efficiency of seeded fibril growth depends on the 
amount and/or length of the protofibrils 
The observation of seeded protofibril-to-fibril conversion 
(Figure 1) does not prove that protofibrils are on- 
pathway intermediates. In order to address whether this 
is the case, we investigated the relationship between 
protofibril formation/growth and the time course of the 
seeded conversion. As our methodology does not allow 
us to measure the amount of protofibrils, we instead 
focused on the average length of the observed protofib- 
rils, which, like the amount of protofibrillar Apl-40 [12], 
increases over time (see above). If protofibrils are merely 
an off-pathway reservoir for A@, the efficiency of seeded 
conversion should be independent of the amount of 
protofibrils and/or their length. If the rate of A/3 dissocia- 
tion from the protofibril is slow, however, seeded growth 
should be less effective as protofibril amount/length 
increases. AFM studies show that shortening of protofib- 
rils on dilution occurs slowly (data not shown) and dialy- 
sis studies show that the protofibril-to-fibril transition is 
faster than protofibril dissolution (D. Walsh and 
D. Teplow, unpublished observations). 
The opposite phenomenon was observed; that is, the 
seeded conversion of protofibrils to fibrils occurred much 
more rapidly from a preincubated sample containing 
longer protofibrils (Figure 2b; total [APl-401 = 100 PM, 
preincubated for 13 days) compared to a sample contain- 
ing short protofibrils but an equal Apl-40 total concentra- 
tion (composed of monomeric AP plus protofibrillar AD 
plus all nonadsorbed species; Figure Za, preincubated less 
than 5 minutes). One day after seeding of the long 
protofibrils sample, long (> 5 l.trn) fibrils were commonly 
observed and the amount of protofibrils had decreased 
significantly (Figure Zb); after 7 days, protofibrils were 
rare and fibril formation was essentially complete. In con- 
trast, one day after seeding the preincubated sample, the 
solution remained unchanged except for the rare appear- 
ance of isolated fibrils (Figure Za); protofibrils were still 
the predominant species after 7 days (in the absence of 
added seed, fibrils were not observed in the incubation 
containing short protofibrils after 7 days). 
Fibrils have an inherent helical twist 
Images of the type 1 fibril at high magnification 
(Figure 3a) clearly show a left-handed helical orientation 
to the periodic height increases (period = -43 nm) along 
the length of the fibril. It is possible that simple beaded 
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Figure 2 
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The efficiency of seeding depends on protofibril length. Abl-40 was 
preincubated at 100 uM for 5 min (a) or 13 days (b), then identical 
amounts (-1 o/, of the initial Abl-40 concentration) of preformed fibrils 
from the same source were added to seed the conversion to fibrils. An 
incubation containing monomeric Ab and short protofibrils was slowly 
converted to fibrils (a), whereas an incubation containing long 
protofibrils was rapidly converted (b). All images are 2 urn square. 
objects could have a helical appearance if the tip used to 
scan them was irregularly shaped, but two separate obser- 
vations rule out this possibility. First, the observed helic- 
ity is the same regardless of the orientation of the fibrils in 
the image. Furthermore, type 1 fibrils formed by all-D 
Apl-40 showed identical periodicity of the height 
increases and were also clearly helical (Figure 3b), but the 
twist direction was always observed to be right-handed. 
The seeding behavior of the enantiomeric fibrils was also 
examined. Aliquots of protofibrils formed by each enan- 
tiomer were separately seeded by adding fibril suspen- 
sions (5% of the initial AP concentration) formed by either 
the same or the opposite enantiomer. Acceleration of fibril 
formation was only observed when the fibrillar.seed mate- 
rial was formed by the same enantiomer of Apl-40 as the 
protofibrils. This is consistent with previous observations 
of amyloid seeding specificity (reviewed in [Z]). 
Branched type 1 fibrils were observed 
Branched type 1 fibrils were also observed (Figures 2,4). At 
some branch points, both of the ‘daughter’ fibrils resembled 
type 1 fibrils (Figure 4a). At others, one of the daughter 
fibrils had a different morphology (Figure 4c; see discussion 
below). Although amyloid librils are typically described as 
unbranched, light scattering data have been interpreted to 
reflect a low degree of Afil-40 fibril branching under certain 
conditions [ 151. 
Partially wound/unwound type 1 fibrils and constituent 
rigid filaments were observed 
As the protofibril disappeared over time, type 1 fibrils 
became the predominantly observed species. The ends of 
type 1 fibrils were often characterized by staggered fila- 
ment termination (Figure 4a; also observed in high resolu- 
tion AFM studies using multiwalled carbon nanotube 
probes; S. Wong, J.D.H., P.T.L., and C.M.L., unpublished 
observations). Isolated rigid filaments (Figure 4b) and 
junctions between type 1 Iibrils and two diverging fila- 
ments (Figures 4, 5) were also observed but only at late 
incubation times when protofibrils were no longer present. 
These filaments were -40% the height of type 1 fibrils 
(3-4 nm), similar to Apl-40 protofibrils [9]. The filaments, 
however, were morphologically distinct from protofibrils, 
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Figure 3 
Helicity of type 1 fibrils. (a) Details of a type 
1 fibril formed by all-L Apl-40. The helical 
nature of the periodic height increases 
(period -43 nm) along the length of the fibril 
in the height data image on the left (brighter 
areas indicate taller features) and the fibril is 
clearly resolved as left-handed in the image 
on the right. This image was generated by 
plotting simultaneously acquired cantilever 
oscillation amplitude data which emphasize 
that rapid changes in height-bright areas 
correspond to decreases and dark areas to 
increases in cantilever oscillation amplitude 
during the scan. (b) Details of a type 1 fibril 
formed by all-o APl-40. The periodicity of 
these fibrils is identical to those formed by 
the all-L peptide and also clearly has a handed. Although the fibrils appear to have 
helical orientation which is emphasized in the different widths, the heights of adsorbed this magnitude are consistent with variations 
amplitude image on the right. For all-D APl- type 1 fibrils formed by each peptide are in broadening artifacts caused by differences 
40, however, the observed helicity is right- indistinguishable, and width differences of in tip shape. Scale bar = 50 nm. 
as they had a 40 nm periodic substructure (protoflbrils have 
a 20 nm periodicity), appeared to be rigid (protofibrils 
appeared to be flexible), and were often longer than 1 pm 
(protofibrils were usually < 200 nm [9]). Type 1 fibril/fila- 
ment junctions may represent trapped, partially wound or 
unwound type 1 fibrils that exist at least transiently in solu- 
tion. Isolated rigid filaments may result from complete 
unwinding of type 1 fibrils. 
Discussion 
The AFM-studies reported here allowed the observation 
of a subpopulation of AP-derived species (the adsorbable 
species) at time points during fibril assembly. As all 
species may not be equally well adsorbed, it is not possi- 
ble to determine the relative stability of these species on 
the basis of their abundance, nor is it possible to rule out 
the existence of other species that might be very poorly 
adsorbed. In order to test the possibility that selective 
adsorption may bias our observations, we have performed 
initial experiments using hydrophobic, highly ordered 
pyrolytic graphite surfaces rather than hydrophilic mica 
surfaces. The same Apl-40-derived species and no addi- 
tional species were detected (data not shown). Although it 
is possible that adsorption traps species that are normally 
Figure 4 
1 
Winding/unwinding and branching of API -40 fibrils. (a) A fibril that is 
partially wound at one end and branched at the other (1 pm square). 
The inset shows a schematic interpretation of the morphology. 
(b) Fibril unwinding and branching (2 pm square). (c) An enlargement 
Chemistry &Biology 
of a central region of (b), showing branching in more detail (500 nm 
square). The inset shows a cross-section along the indicated plane 
(blue arrow) that clearly shows the transition from 3-5 nm single 
filament to 7-9 nm type 1 fibril. 
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Figure 5 
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The temporal evolution of APl -40-derived 
species. (a) At the earliest time points, the 
only observed A/31 -40 aggregates are short 
protofibrils [91. (b) Subsequently, longer 
protofibrils become increasingly common. 
(c) After 3-4 weeks, or l-7 days following 
the addition of preformed fibrils, both 
protofibrils and long type 1 fibrils are seen. 
Branching of fibrils is frequently observed at 
this stage (see days 4 and 7 in Figure 2). 
Changing color from red for protofibrils to 
green for fibrils reflects a putative 
conformational change suggested by the 
increased rigidity and different periodicity of 
filaments compared to protofibrils. (d) In the 
late stages, protofibrils are no longer 
observed. In addition to type 1 fibrils and 
branched type 1 fibrils, isolated rigid filaments 
and junctions are observed. 
sparsely populated in solution (e.g., unwound type 1 
fibrils), the observation of these potentially kinetically 
important species may provide clues as to the mechanism 
of fibril assembly. Using alternative methods, Teplow and 
co-workers [12] have recently determined that a signifi- 
cant proportion of total soluble AP is rapidly converted to a 
protofibrillar species, which subsequently disappears as 
dense, highly insoluble fibrils form. The temporal evolu- 
tion of the APl-40-derived species imaged in this work is 
shown in Figure 5. 
The observed species fall into three classes, on the basis 
of their dimensions and surface topography as determined 
by AFM. First to appear are the flexible protofibrils, 
which have an axial periodicity of -20 nm, and are 3-4 nm 
in height [9]. Protofibrils grow slowly (to -200 nm) until 
type 1 fibrils are observed, and are then rapidly consumed 
[9,12]. The protofibrils are in equilibrium with monomeric 
AP; slow dissolution of protofibrils occurs at high dilution 
(data not shown). The next species to appear is type 1 
librils; usually well over 1 l.trn long, with a left-handed 
helical structure (axial periodicity of about 43 nm; right- 
handed helicity of identical periodicity is observed for 
type 1 fibrils comprising all-D Afil-40), and a height that is 
approximately 2.5 times that of the protofibril. After the 
protofibrillar population has been consumed, filaments 
appear that are rigid and long like type 1 fibrils, have axial 
periodicity resembling the type 1 fibril, but have a height 
that is indistinguishable from the protofibril. The helicity 
and dimensions of the type 1 fibril and the dimensions of 
the rigid and long filaments are consistent with a two-fila- 
ment wound morphology for the type 1 fibril. There is a 
well established precedent for the two-filament wound 
morphology (see below). The morphological differences 
between the rigid filaments and the flexible protofibrils 
may reflect a critical conformational change (red to green 
in Figure 6). 
Information about seeded growth can be inferred from the 
observation of seeded fibril formation. First, as only mix- 
tures of morphologies including type 1 fibrils, but not 
protofibrils alone, are competent seeds, the nucleation- 
dependent step may be the transition from protofibril-to- 
type 1 fibril, consistent with the sudden appearance of long 
type 1 fibrils [9]. Second, because the protofibril is a more 
effective seeding substrate, its addition to the seed may be 
favored, although the direct addition of monomeric 
[l&16-18], dimeric [ 1’21, or higher AP oligomers may also 
occur. These data can be used to construct a testable 
mechanistic model for seeded Apl-40 fibril growth, in 
which the rigid type 1 fibril-derived filament acts as a site 
for protofibril addition and catalyzes a conformational 
change (Figure 6; [19]). 
Although these studies were conducted under conditions 
that differ from those under which fibril formation is initi- 
ated in &JO [1,4,8,14], three facts support the relevance of 
the in vitro process. First, protofibril formation has been 
Research Paper imaging of amyloid-p fibril formation Harper et al. 957 
Figure 6 
A working hypothesis to explain seeded 
amyloid fibril growth. Oligomeric A!3 species 
that have been directly observed by AFM (see 
Figure 5) are shown in boxes. Inferred species 
(unboxed) and hypothetical pathways to 
explain the interconversion of species (dashed 
arrows with question marks) are included. In 
the earliest stages of fibril formation, 
monomeric (or dimeric [12]) Ab rapidly 
oligomerizes to form short protofibrils. The 
average length of the observed protofibrils 
(and the total amount [121) increases with 
time. Nucleus formation may involve 
annealing, winding, and an irreversible 
conformational change (red to green) to 
produce a type 1 fibril. The conformational 
change provides an explanation for the 
apparent cooperativity of fibril formation and 
could lead to a preorganized single filament 
seed template that is an optimal binding site 
for addition of a subsequent protofibril. The 
addition of seed containing a mixture of 
fibrillar species (shown in square brackets) 
bypasses nucleation. An exposed rigid 
filament could seed growth by catalyzing the 
conformational change in an added protofibril, 
analogous to flagellar assembly 1191. Fibril 
morphologies with exposed rigid filaments 
could arise if protofibrils with different lengths 
or offset alignments associate and wind to 
r 
q - Observed by AFM 
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produce a fibril end with staggered 
termination of filaments (i), or if fibril ends can elongation may also occur by addition of Aj3 
transiently or completely unwind ((iii) to monomer/small AP oligomer onto filament 
expose single filament templates. Addition of a ends [12,16-l 81. Detailed kinetic studies, 
protofibril to an exposed filament could lead to utilizing multiple methods to characterize and 
unbranched elongation of a type 1 fibril (iv,vi), quantify all intermediates [8,12-l 41, are 
or to branched morphology (v). Fibril required to test this model. 
observed under a variety of conditions; second, AD brain- 
derived amyloid fibrils have a two-filament wound mor- 
phology; and third, amyloid fibrils comprising other 
proteins have a similar wound morphology. Since the con- 
centration of AP, averaged throughout the brain, is well 
below the critical concentration (the concentration of AP 
below which fibrils do not form) [8], the site of in viva 
amyloid growth is likely to be a cellular compartment, 
where AP is locally concentrated. We have observed 
protofibril formation in vitro at APl-40 concentrations that 
approach the critical concentration of -3OpM [9] and over 
a range of ionic strengths, pHs, and buffer compositions 
(J.D.H., unpublished observations). 
The morphological similarities of brain-derived fibrils to 
those formed in vitro also support the relevance of the in 
vitro studies reported here. Amyloid fibrils, observed in AD 
brain tissue sections by electron microscopy, seem to be 
composed of two wound 4-7 nm diameter filaments [20,21]. 
Miyakawa et al. [ZZ] propose a hollow-centered bundle of 
helically wound subunits; however, their data are also con- 
sistent with the winding of two semicylindrical filaments. 
Amyloid preparations extracted from AD brain also have a 
wound morphology; Roher et al [23,24] observed -5nm 
wide filaments, in addition to typical 10 nm wide tibrils, 
suggesting winding/unwinding. Merz et al. [ZO] noted a 
40nm periodicity in the 1Onm wide fibrils, reminiscent of 
the Apl-40 type 1 fibrils formed in vitro by our group [9]. 
The 40nm periodicity and branching also characterized 
Apl-40 fibrils produced in vitro by another laboratory [ZS]. 
Fibrils that characterize other amyloid diseases comprising 
other peptides and proteins share some of these features. 
Amyloid fibrils of the prion protein, isolated from the 
brains of human and rodent scrapie cases, are character- 
ized by a two-filament wound morphology [ZO]. 
Transthyretin amyloid fibrils seem to be composed of 
bundles of four ‘protofilaments’, each of which has been 
proposed to consist of two wound filaments (the twist 
periodicity is -11.5 nm; [26]). Fibrils comprising islet 
amyloid polypeptide (the major constituent of pancreatic 
amyloid that characterizes type II diabetes) and the 
peptide calcitonin (-8 nm diameter) have also been pro- 
posed to be derived from annealing and winding of 
protofibrils [27,28]. Finally, cytokeratin fibrils (reconsti- 
tuted from purified cytokeratin isolated from fibrillar 
deposits in diseased livers) have a similar twisted filament 
morphology (-40 nm periodicity) and have also been 
observed to partially wind/unwind [29]. 
In order to demonstrate unequivocally the importance of 
the transient species reported here, the same species must 
be identified in, or extracted from, AD brain tissue. 
Protofibrils are most likely to be found in the brains of 
individuals predisposed to develop AD, such as young 
Down’s syndrome [30] and head trauma patients [31]. In 
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both of these groups, significant deposition of AP, in a non- constant (5 5% by volume) by adding DMSO to the sample buffer of 
fibrillar form called diffuse amyloid, precedes symptoms the less concentrated A/31-40 solutions. After initial mixing the solu- 
[30,31]. Diffuse amyloid has been proposed to be a precur- 
tions were incubated at room temperature without further agitation 
sor of fibrillar amyloid [32], and contains protofibrils [9]. 
except for gentle tapping to ensure homogeneous aliquots for AFM. 
Significantly, the in vitro neurotoxicity of cdmmercial APl- Seeding experiments 
40 seems to be inversely correlated with the prevalence of 100 pM solutions of Apl-40, containing long protofibrils (after > 1 
nonfibrillar species that we believe are protofibrils [25]. week preincubation) were divided in two. One portion was left unal- 
This finding suggests that inhibition of the protofibril-to- 
tered and the other portion was seeded by adding preformed seed 
fibril transition may prevent in vivo neurodegeneration [4]. 
fibrils and filaments (I lo/, of a molar equivalent based on initial total 
[Apl-40]), but no protofibrils (morphology confirmed by AFM just prior 
to use). At the same time, a 100 uM AL31 -40 solution that was not 
Significance preinchbated was also seeded witi the iame amount of the identical 
Accumulating evidence indicates that the formation of 
seed stock. The seed stock was diluted into buffer containing no 
amyloid plaques in the brain is a central event in 
APl-40 and imaged to determine the contribution of seed fibrils to the 
observed images; no fibrils were detected, indicating that the observed 
Alzheimer’s disease (AD) pathogenesis. The plaques fibrils in the seeded growth incubations are attributable to new growth, 
are primarily composed of the fibrillar form of the rather than the seed aliquot. 
amyloid-fi protein (AP). In this study, atomic force 
microscopic images of seeded AP fibril growth in vitro 
show that fibril growth can be seeded by the addition of 
preformed fibrils, but not by preformed protofibrils, and 
that protofibrils are incorporated into growing fib&. 
New morphological features, including fibril branching 
and fibril winding/unwinding, have been observed, and 
the helicity of fibrils has been demonstrated. This infor- 
mation provides the basis for a testable model for seeded 
fibril growth in vitro. In this model, the nucleation- 
dependent step occurs during the transition of proto- 
fibrils-to-fibrils and exposed single filaments act as a 
template for annealing, winding and rigidifkation of 
protofibrils during fibril growth. 
The direct role of the protofibril in type 1 fibril formation 
in vitro strongly suggests that the protofibril also plays an 
important role in the formation of the morphologically 
indistinguishable amyloid fibrils in the brains of individu- 
als with AD. Protofibrils would be expected to form early 
in AD, possibly preceding the death of neurons and the 
appearance of symptoms. Agents that inhibit the proto- 
tibril-to-fibril transition of AP in vitro may lead the way 
to developing therapeutic agents to combat AD. 
Materials and methods 
Protein substrate 
Synthetic APl-40 was purchased from Quality Controlled Biochemi- 
cals Inc. (Hopkinton, MA). Synthetic Apl-40 made using all-D amino 
acids was provided by Michael Vitek (Duke University). 
Preparation of seed-free A/U -40 stock solutions 
Stock solutions of AD1 -40 in dimethyl sulfoxide (DMSO) were prepared 
at a concentration of approximately 12 mg/ml. The peptide solution was 
then sonicated for 5-10 min and iilteredthrough a 0.2 pm nylon micro- 
spin filter (Whatman Inc., Clifton, NJ) to remove any undissolved seed. 
Final peptide concentrations of the DMSO stock solutions, as deter- 
mined by quantitative amino analysis, were typically 2-2.5 mM. 
In vitro aggregation of A/31 -40 
AP aggregation was initiated by adding an aliquot of a concentrated 
DMSO stock of Apl-40 to aqueous buffer (10 mM phosphate, 137 mM 
NaCI, 27 mM KCI, pH 7.4) followed by immediate vortexing to mix thor- 
oughly. The concentration of DMSO in the aggregation buffer was kept 
Atomic force microscopy 
The incubating samples were mixed by gentle tapping to evenly suspend 
any aggregates, and 3-5 pl aliquots were placed on freshly cleaved mica 
(Ted Pella, Redding, CA). After 3Os, the mica was gently rinsed twice 
with 50 pl of 0.2 pm-filtered water to remove salt and loosely bound 
peptide. Excess water was removed with a gentle stream of filtered com- 
pressed tetrafluoroethane, and the samples were imaged immediately. All 
images were obtained under ambient conditions with a Nanoscope llla 
Multimode scanning probe workstation (Digital Instruments, Santa 
Barbara, CA) operating in TappingModeTM using etched silicon 
NanoProbesTM (Probe Model TESP, Digital Instruments). Scanning para- 
meters varied with individual tips and samples, but typical ranges were as 
follows: initial root mean square (RMS) amplitude, 1.2V; setpoint, 
0.9-l .l V; tapping frequency, 250-350 kHz; scan rate, 0.8-l .75 Hz. 
Measurement of A/? oligomer dimensions 
Protofibril length average. Aliquots were diluted to 20 PM APl-40 
immediately prior to sample preparation to allow individual protofibrils to 
be discerned and measured. Consecutive scans were monitored until 
distortion due to creep or shifts in the slow scan direction were negligi- 
ble. An area containing 50-70 protofibrils was chosen, and all protofib- 
rils within this region were measured by summing the lengths of short 
line segments (in top view mode in the Nanoscope software) drawn to 
approximate the curvature of the protofibrils (globular aggregates mea- 
suring 5 20 nm and showing no evidence of elongation were counted in 
each region, but were not included in protofibril length averages). 
Comparison of morphology heights. Because variations in sample 
hydration, scanner calibration, and applied forces during imaging can 
alter the observed dimensions of protein samples, quantitative height 
comparisons are based on data obtained from single scans of regions 
where the morphologies to be compared both appear. To allow height 
comparison between protofibril and filament (which are not clearly 
observed together in single scans), the average fibril (type 1) height 
(present with protofibrils and filaments) was used as an internal height 
calibration standard. Cross sections of features were r,nade perpendic- 
ular to the long axis of the feature at periodic height maxima to obtain 
feature height averages (at least 30 measurements of separate cross 
sections for each average). 
Periodicity measurements. Averages of 30 separate peak-to-peak 
distances were made for each morphology with observed regular 
periodicities. 
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